Synthesis and Evaluation of Anti-acetylcholinesterase Activity of Some Benzothiazole Based New Piperazine-dithiocarbamate Derivatives

Abstract

In this present study some benzothiazole derivatives bearing piperazine and thiocarbamate moieties were synthesized and their potential anticholinesterase properties were investigated. A set of 30 new compounds of 2-[(6-substituted benzothiazol-2-yl)amino]-2-oxoethyl 4-substituted piperazine-1-carbodithioate derivatives were synthesized by reacting 2-chloro-N-(6-substituted benzothiazole-2-yl)acetamide derivatives derivatives and sodium salts of appropriate N,N-disubstituted dithiocarbamic acids in acetone. The structures of the obtained compounds were elucidated using FT-IR, ¹H-NMR and MS spectral data and elemental analyses result. Each derivative was evaluated for its ability to inhibit acetylcholinesterase (AChE) using a modificated Ellman’s spectrophotometric method. Some of the compounds can be identified as anticholinesterase agents due to their inhibitory effect when compared with Donepezil. Compounds with dimethylamino ethyl or dimethylamino propyl substituents were defined as the anticholinesterase active compounds.

Key words

benzothiazole - piperazine - dithiocarbamate - cholinesterase inhibitors

• References

• 1 Silverman RB. The Organic Chemistry of Drug Design and Drug Action. 2^nd ed. Elsevier Academic Press; Burlington: 2004
• 2 Shen ZX. Brain Cholinesterases: III. Future perspectives of AD research and clinical practice. Med Hypotheses 2004; 63: 298-307
• 3 Martinez A, Castro A. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease. Expert Opin Investig Drugs 2006; 15: 1-12
• 4 Giacobini E. Cholinesterases: New roles in brain function and in Alzheimer’s Disease. Neurochem Res 2003; 28: 515-522
• 5 Sing M, Kaur M, Kukreja H et al. Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection. Eur J Med Chem 2013; 70: 165-188
• 6 Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer’s disease. Drugs 2001; 61: 41-52
• 7 Pepeu G, Giovannini MG. Cholinesterase inhibitors and beyond. Curr Alzheimer Res 2009; 6: 86-96
• 8 Altintop MD, Kaplancikli ZA, Ozdemir A et al. Synthesis and anticholinesterase activity and cytotoxicity of novel amide derivatives. Arch Pharm Chem Life Sci 2012; 345: 112-116
• 9 Johannsen P. Long-term cholinesterase inhibitor treatment of Alzheimer’s Disease. CNS Drugs 2004; 18: 757-768
• 10 Grossberg GT. Cholinesterase inhibitors for the treatment of Alzheimer’s Disease: – Getting on and staying on. Curr Ther Res Clin Exp 2003; 64: 216-235
• 11 Wilkinson DG, Francis PT, Schwam E et al. Cholinesterase inhibitors used in the treatment of Alzheimer’s disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 2004; 21: 453-478
• 12 Lemke TL, Williams DA. Foye’s Principles of Medicinal Chemistry. 7^th ed. Lippincott Williams & Wilkin; Baltimore: 2008
• 13 Madalageri PM, Kotresh O. Synthesis, DNA protection and antimicrobial activity of some novel chloromethyl benzimidazole derivatives bearing dithiocarbamates. J Chem Pharm Res 2012; 4: 2697-2703
• 14 Waterbeemd H, Mannhold R In: Lipophilicity in Drug Action and Toxicology. Pliska V, Testa B, Waterbeemd H. (ed.). VCH Publishers; New York: 1996: 401-418
• 15 Tokuyama R, Takahashi Y, Tomita Y et al. Structure-activity relationship (SAR) studies on oxazolidinone Antibacterial agents. 2. Relationship between lipophilicity and antibacterial activity in 5-thiocarbonyl oxazolidinones. Chem Pharm Bull 2001; 49: 353-360
• 16 Patani GA, LaVoie EJ. Bioisosterism:  A rational approach in drug design. Chem Rev 1996; 96: 3147-3176
• 17 Duan YC, Ma YC, Zhang E et al. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. Eur J Med Chem 2013; 62: 11-19
• 18 Bacharaju K, Jambula SR, Sivan S et al. Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents. Bioorg Med Chem Lett 2012; 22: 3274-3277
• 19 Turan-Zitouni G, Ozdemir A, Guven K. Synthesis of some 1-[(N,N-disubstituted thiocarbamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and investigation of their antibacterial and antifungal activities. Arch Pharm Chem Life Sci 2005; 338: 96-104
• 20 Sadashiva CT, Narendra Sharath Chandra JN. Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer’s disease. Bioorg Med Chem Lett 2006; 16: 3932-3936
• 21 Yurttaş L, Özkay Y, Kaplancikli ZA. Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2013; 28: 1040-1047
• 22 Varadaraju KR, Kumar JR, Mallesha L et al. Virtual screening and biological evaluation of piperazine derivatives as human acetylcholinesterase inhibitors. Int J Alzheimers Dis 2013; early online DOI: 10.1155/2013/653962.
• 23 Mohammadi-Farani A, Ahmadi A, Nadri H et al. Synthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects. Daru 2013; 21: 21-47
• 24 Keri RS, Quintanova C, Marques SM et al. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer’s disease. Bioorg Med Chem 2013; 21: 4559-4569
• 25 Özkay-Demir Ü, Can ÖD, Özkay Y et al. Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits. Pharmacol Rep 2012; 64: 634-847
• 26 Yurttaş L, Özkay Y, Akalın-Çiftci G et al. Synthesis and anticancer activity evaluation of N-[4-(2-methylthiazol-4-yl)phenyl]acetamide derivatives containing (benz)azole moiety. J Enzyme Inhib Med Chem 2014; 29: 175-184
• 27 Ellman GL, Courtney KD, Andres V et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95
• 28 Perry NSL, Houghton PJ, Theobald AE et al. In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 2000; 52: 895-902